Genotype-Phenotype Correlations in Autosomal Dominant Osteogenesis Imperfecta

por Ben Amor, I. Mouna, Glorieux, Francis H., Rauch, Frank
Publicado 2011

Cone‐Beam Computed Tomography of Osteogenesis Imperfecta Types III and IV: Three‐Dimensional Evaluation of Craniofacial Features and Upper Airways

por Reznikov, Natalie, Dagdeviren, Didem, Tamimi, Faleh, Glorieux, Francis, Rauch, Frank, Retrouvey, Jean‐Marc
Publicado 2019

From pediatric to adult care: strategic evaluation of a transition program for patients with osteogenesis imperfecta

por Dogba, Maman Joyce, Rauch, Frank, Wong, Trudy, Ruck, Joanne, Glorieux, Francis H, Bedos, Christophe
Publicado 2014

Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH)

por Glorieux, Francis H., Bonewald, Lynda F., Harvey, Nicholas C., van der Meulen, Marjolein C. H.
Publicado 2022

The impact of severe osteogenesis imperfecta on the lives of young patients and their parents – a qualitative analysis

por Dogba, Maman Joyce, Bedos, Christophe, Durigova, Michaela, Montpetit, Kathleen, Wong, Trudy, Glorieux, Francis H, Rauch, Frank
Publicado 2013

Lung Transplantation in a Patient With Osteogenesis Imperfecta and Osteoporosis

por Fan, Lena, Benvenuto, Luke J, Nolan, Margaret, DiMango, Angela, Shane, Elizabeth, Glorieux, Francis H, Rubin, Mishaela Ruth
Publicado 2021

Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I

por Mähr, Matthias, Blouin, Stéphane, Behanova, Martina, Misof, Barbara M., Glorieux, Francis H., Zwerina, Jochen, Rauch, Frank, Hartmann, Markus A., Fratzl-Zelman, Nadja
Publicado 2021

OR13-2 Characterizing the Impact of Burosumab on Bone Health in Children with X-Linked Hypophosphatemia: Results from Year 1 of the Disease Monitoring Program

por Carpenter, Thomas, Cassinelli, Hamilton, Glorieux, Francis, Hetzer, Joel, Merritt II, J Lawrence, Moreira, Carolina A, Portale, Anthony, Ward, Leanne, Woo, Claudine, Imel, Erik
Publicado 2022

Involving Families with Osteogenesis Imperfecta in Health Service Research: Joint Development of the OI/ECE Questionnaire

por Dogba, Maman Joyce, Dahan-Oliel, Noémi, Snider, Laurie, Glorieux, Francis H., Durigova, Michaela, Palomo, Telma, Cordey, Michel, Bédard, Marie-Hélène, Bedos, Christophe, Rauch, Frank
Publicado 2016

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia

por Ruppe, Mary D., Zhang, Xiaoping, Imel, Erik A., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey S., Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Peacock, Munro, Carpenter, Thomas O.
Publicado 2016

Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia...

por Zhang, Xiaoping, Imel, Erik A., Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey, Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Carpenter, Thomas O., Peacock, Munro
Publicado 2015

OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)

por Imel, Erik, Whyte, Michael, Munns, Craig, Portale, Anthony, Ward, Leanne, Nilsson, Ola, Simmons, Jill, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Mao, Meng, Chen, Chao-Yin, Skrinar, Alison, San Martin, Javier, Glorieux, Francis
Publicado 2019

Mutations in SERPINF1 Cause Osteogenesis Imperfecta Type VI

por Homan, Erica P, Rauch, Frank, Grafe, Ingo, Lietman, Caressa, Doll, Jennifer A, Dawson, Brian, Bertin, Terry, Napierala, Dobrawa, Morello, Roy, Gibbs, Richard, White, Lisa, Miki, Rika, Cohn, Daniel H, Crawford, Susan, Travers, Rose, Glorieux, Francis H, Lee, Brendan
Publicado 2011

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

por Ward, Leanne M, Glorieux, Francis H, Whyte, Michael P, Munns, Craig F, Portale, Anthony A, Högler, Wolfgang, Simmons, Jill H, Gottesman, Gary S, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Nilsson, Ola, Mao, Meng, Chen, Angel, Skrinar, Alison, Roberts, Mary Scott, Imel, Erik A
Publicado 2022

Growth Characteristics in individuals with Osteogenesis Imperfecta in North America - Results from a Multicenter Study

por Jain, Mahim, Tam, Allison, Shapiro, Jay R, Steiner, Robert D, Smith, Peter A, Bober, Michael B, Hart, Tracy, Cuthbertson, David, Krischer, Jeff, Mullins, Mary, Bellur, Sunil, Byers, Peter H, Pepin, Melanie, Durigova, Michaela, Glorieux, Francis H, Rauch, Frank, Lee, Brendan, Sutton, V Reid, Nagamani, Sandesh CS
Publicado 2018

Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level

por Imel, Erik A, Glorieux, Francis H, Whyte, Michael P, Portale, Anthony A, Munns, Craig F, Nilsson, Ola, Simmons, Jill H, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Pitukcheewanont, Pisit, Sochett, Etienne, Högler, Wolfgang, Muroya, Koji, Tanaka, Hiroyuki, Gottesman, Gary S, Biggin, Andrew, Perwad, Farzana, Chen, Angel, Roberts, Mary Scott, Ward, Leanne M
Publicado 2023

A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta

por Bains, Jaskaran S, Carter, Erin M, Citron, Kate P, Boskey, Adele L, Shapiro, Jay R, Steiner, Robert D, Smith, Peter A, Bober, Michael B, Hart, Tracy, Cuthbertson, David, Krischer, Jeff, Byers, Peter H, Pepin, Melanie, Durigova, Michaela, Glorieux, Francis H, Rauch, Frank, Sliepka, Joseph M, Sutton, V Reid, Lee, Brendan, Nagamani, Sandesh CS, Raggio, Cathleen L
Publicado 2019

Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta

por Murali, Chaya N, Cuthbertson, David, Slater, Brady, Nguyen, Dianne, Turner, Alicia, Harris, Gerald, Sutton, V Reid, Lee, Brendan, Nagamani, Sandesh CS, Rauch, Frank, Glorieux, Francis, Retrouvey, Jean-Marc, Esposito, Paul, Rush, Eric, Bober, Michael, Eyre, David, Gomez, Danielle, Hart, Tracy, Jain, Mahim, Krakow, Deborah, Krischer, Jeffrey, Orwoll, Eric, Raggio, Cathleen, Smith, Peter, Tosi, Laura
Publicado 2019

Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia

por Padidela, Raja, Whyte, Michael P., Glorieux, Francis H., Munns, Craig F., Ward, Leanne M., Nilsson, Ola, Portale, Anthony A., Simmons, Jill H., Namba, Noriyuki, Cheong, Hae Il, Pitukcheewanont, Pisit, Sochett, Etienne, Högler, Wolfgang, Muroya, Koji, Tanaka, Hiroyuki, Gottesman, Gary S., Biggin, Andrew, Perwad, Farzana, Williams, Angela, Nixon, Annabel, Sun, Wei, Chen, Angel, Skrinar, Alison, Imel, Erik A.
Publicado 2021